Citius Pharma Completes Enrollment in Phase 3 Trial for Mino-Lok® Catheter Salvage

Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercial...

January 03, 2024 | Wednesday | News
Avenue Therapeutics Completes Enrollment in Clinical Trial for AJ201 in Kennedy's Disease

Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development...

January 03, 2024 | Wednesday | News
Pasithea Therapeutics' PAS-004 IND Application Accepted by FDA for Advanced Cancer Patient Evaluation.

-- Phase 1 dose escalation study in patients with MAPK pathway driven advanced solid tumors to begin in Q1 2024 – -- Initial readout expected as ear...

January 03, 2024 | Wednesday | News
Boston Scientific Launches AVANT GUARD Trial for FARAPULSE™ in Atrial Fibrillation

Unlike paroxysmal AF, which describes symptoms that last for seven days or fewer, persistent AF is a sustained arrhythmia that lasts for more than a week1....

January 01, 2024 | Monday | News
Cell BioEngines Partners with Miltenyi Bioindustry for Hematopoietic Cell Therapy Program Manufacturing

Cell BioEngines, Inc., a clinical-stage biotechnology company focused on delivering novel, innovative stem cell and immune cell therapies to address blood ...

January 01, 2024 | Monday | News
Enveric Biosciences Updates Year-End Progress on Lead Prodrug Candidate EB-373

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neur...

December 28, 2023 | Thursday | News
Innovent, Xuanzhu Collaborate on Clinical Trial for Advanced Solid Tumors in China

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

December 28, 2023 | Thursday | News
Elpiscience, Astellas Partner on Bispecific Macrophage Engager

The two companies will collaboratively conduct early-stage research for these two programs. Elpiscience will also grant Astellas the right to add up to two...

December 28, 2023 | Thursday | News
Senti Bio Receives FDA Clearance for SENTI-202 in Hematologic Malignancies

Initial clinical efficacy data expected by year-end 2024 and durability data expected in 2025 – – SENTI-202 is a potential first-in-class of...

December 26, 2023 | Tuesday | News
AlloVir Updates Phase 3 Program for Posoleucel T Cell Therapy

Company to discontinue its three Phase 3 posoleucel studies following separate, pre-planned DSMB futility analyses concluding the studies were unlikely to ...

December 26, 2023 | Tuesday | News
JCR and Alexion Partner on Oligonucleotide Therapeutics Using J-Brain Cargo® Technology

-JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida: “JCR”) announces that it has signed a Research Collaboration, Op...

December 22, 2023 | Friday | News
FDA Approves Label Update for Yescarta® CAR T-Cell Therapy with Overall Survival Data

Kite, a Gilead Company (Nasdaq: GILD), announced that the U.S. Food and Drug Administration (FDA) has approved a label update for Yescarta® (axicabtage...

December 22, 2023 | Friday | News
Multiply Labs and Akron Bio Collaborate to Automate cGMP-Compliant Liquid Cytokines in Cell Therapy Manufacturing

Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and Akron Bio (“Akron&...

December 21, 2023 | Thursday | News
Atomic AI Optimizes RNA Therapeutic Development with Chemical Mapping Data

Atomic AI’s ATOM-1 large language model (LLM) demonstrates state-of-the-art accuracy for predicting RNA structure and function Technology can be exp...

December 18, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close